Deschatelets Pascal

Insider CIK 1657720 · APLS Chief Scientific Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	108,622	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	9,805	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	30,845	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	45,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	56,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	50,974	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	95,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	110,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	82,500	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	1,177,222	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	25,840	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	11,284	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	3,372	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	4,909	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	25,840	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	25,840	—	$0	25,840	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	12,920	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	12,920	—	$0	12,920	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	10,030	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	10,030	—	$0	10,030	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	41,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	41,250	—	$0	41,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-01-28	2026-01-30	25,840	—	$0	1,177,222	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-22	2026-01-23	5,928	$21.77	$129.1K	1,151,382	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-20	2026-01-21	909	$19.79	$18.0K	1,157,310	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-13	2026-01-15	2,277	$22.19	$50.5K	1,158,219	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2025-06-09	2025-06-11	82,500	$19.39	$1.60M	82,500	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2025-05-21	2025-05-22	12,780	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2025-05-21	2025-05-22	12,780	$3.76	$48.1K	1,160,496	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-29	2025-01-30	826	$29.52	$24.4K	1,147,716	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-22	2025-01-23	3,948	$30.43	$120.1K	1,148,542	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-01-21	2025-01-21	15,045	—	$0	1,152,490	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-17	2025-01-21	750	$29.96	$22.5K	1,137,445	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-13	2025-01-14	2,288	$28.70	$65.7K	1,138,195	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-05-20	2024-05-21	24,500	—	$0	12,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-05-20	2024-05-21	24,500	$3.76	$92.1K	1,140,483	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-05-08	2024-05-09	78,907	—	$0	108,622	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-05-08	2024-05-09	100	$44.03	$4.4K	1,115,983	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-05-08	2024-05-09	78,907	$4.31	$340.1K	1,194,890	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-05-08	2024-05-09	56,335	$42.15	$2.37M	1,138,555	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-05-08	2024-05-09	22,472	$42.85	$962.9K	1,116,083	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-04-08	2024-04-09	69,107	—	$0	37,280	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-04-08	2024-04-09	64,379	$54.12	$3.48M	1,120,711	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-04-08	2024-04-09	4,728	$54.92	$259.7K	1,115,983	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-04-08	2024-04-09	69,107	$3.76	$259.8K	1,185,090	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-03-08	2024-03-11	69,107	—	$0	106,387	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-08	2024-03-11	26,257	$62.69	$1.65M	1,116,083	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-03-08	2024-03-11	69,107	$3.67	$253.6K	1,185,090	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-08	2024-03-11	42,750	$61.88	$2.65M	1,142,340	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-08	2024-03-11	100	$63.35	$6.3K	1,115,983	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-02-12	2024-02-13	1,148	$67.77	$77.8K	1,115,983	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-29	2024-01-31	874	$64.14	$56.1K	1,117,131	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-22	2024-01-23	3,913	$65.00	$254.3K	1,118,005	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2024-01-16	2024-01-17	9,805	$66.30	$650.1K	9,805	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-16	2024-01-17	1,632	$66.81	$109.0K	1,121,918	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2024-01-16	2024-01-17	6,743	—	$0	1,123,550	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-11-14	2023-11-15	45,000	—	$0	175,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-11-14	2023-11-15	45,000	$3.76	$169.2K	1,116,807	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-11-08	2023-11-09	17,494	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-11-08	2023-11-09	17,494	$2.67	$46.7K	1,083,807	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-11-08	2023-11-09	12,000	$47.27	$567.2K	1,071,807	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-10-09	2023-10-10	18,500	—	$0	17,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-10-09	2023-10-10	18,500	$2.67	$49.4K	1,078,313	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-10-09	2023-10-10	12,000	$40.38	$484.6K	1,066,313	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-09-08	2023-09-11	18,500	—	$0	35,994	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-09-08	2023-09-11	18,500	$2.67	$49.4K	1,071,813	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-09-08	2023-09-11	12,000	$42.87	$514.4K	1,059,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-08-08	2023-08-09	18,500	—	$0	54,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-08-08	2023-08-09	18,500	$2.67	$49.4K	1,065,313	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-08-08	2023-08-09	12,000	$23.66	$283.9K	1,053,313	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-07-10	2023-07-11	18,500	—	$0	72,994	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-07-10	2023-07-11	12,000	$84.55	$1.01M	1,046,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-07-10	2023-07-11	18,500	$2.67	$49.4K	1,058,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-06-08	2023-06-09	18,500	—	$0	91,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-06-08	2023-06-09	18,500	$2.67	$49.4K	1,052,313	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-06-08	2023-06-09	12,000	$91.35	$1.10M	1,040,313	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-05-08	2023-05-09	18,500	—	$0	109,994	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-08	2023-05-09	12,000	$92.39	$1.11M	1,033,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-05-08	2023-05-09	18,500	$2.67	$49.4K	1,045,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-04-10	2023-04-11	18,500	—	$0	128,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-04-10	2023-04-11	18,500	$2.67	$49.4K	1,039,313	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-04-10	2023-04-11	12,000	$78.21	$938.5K	1,027,313	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-08	2023-03-10	18,500	—	$0	146,994	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-03-08	2023-03-10	12,000	$63.79	$765.5K	1,020,813	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-08	2023-03-10	18,500	$2.67	$49.4K	1,032,813	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-02-21	2023-02-22	14,023	—	$0	14,023	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-02-21	2023-02-22	9,886	—	$0	1,015,508	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-21	2023-02-22	1,195	$58.50	$69.9K	1,014,313	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-10	2023-02-14	1,134	$51.21	$58.1K	1,005,622	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-02-08	2023-02-10	18,500	—	$0	165,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-02-08	2023-02-10	18,500	$2.67	$49.4K	1,018,756	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-02-08	2023-02-10	12,000	$54.45	$653.4K	1,006,756	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-27	2023-01-30	832	$52.77	$43.9K	1,000,256	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-20	2023-01-24	2,326	$52.05	$121.1K	1,001,088	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-01-12	2023-01-17	30,845	$52.66	$1.62M	30,845	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-12	2023-01-17	19,634	—	$0	1,003,414	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-01-09	2023-01-10	18,500	—	$0	183,994	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-01-09	2023-01-10	18,500	$2.67	$49.4K	995,780	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-01-09	2023-01-10	12,000	$46.08	$553.0K	983,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-29	2022-12-30	7,000	—	$0	220,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-29	2022-12-30	7,000	$3.67	$25.7K	977,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-08	2022-12-12	18,500	—	$0	202,494	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-12-08	2022-12-12	12,000	$47.50	$570.0K	970,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-08	2022-12-12	18,500	$2.67	$49.4K	982,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-11-08	2022-11-10	18,500	—	$0	220,994	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-11-08	2022-11-10	12,000	$46.47	$557.6K	963,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-11-08	2022-11-10	18,500	$2.67	$49.4K	975,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-10-10	2022-10-11	18,500	—	$0	239,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-10-10	2022-10-11	18,500	$2.67	$49.4K	969,280	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-10-10	2022-10-11	12,000	$57.50	$690.0K	957,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-09-08	2022-09-12	18,500	—	$0	257,994	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-09-08	2022-09-12	18,500	$2.67	$49.4K	962,780	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-09-08	2022-09-12	12,000	$63.98	$767.8K	950,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-08-08	2022-08-09	18,500	—	$0	276,494	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-08-08	2022-08-09	12,000	$62.50	$750.0K	944,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-08-08	2022-08-09	18,500	$2.67	$49.4K	956,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-07-08	2022-07-12	12,000	—	$0	301,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-07-08	2022-07-12	6,500	—	$0	294,994	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-07-08	2022-07-12	12,000	$47.95	$575.4K	937,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-07-08	2022-07-12	6,500	$2.67	$17.4K	949,780	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-07-08	2022-07-12	12,000	$2.67	$32.0K	943,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-06-17	2022-06-22	33,005	—	$0	313,494	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-06-17	2022-06-22	33,005	$2.67	$88.1K	931,280	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-06-08	2022-06-09	12,000	—	$0	352,999	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-06-08	2022-06-09	6,500	—	$0	346,499	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-06-08	2022-06-09	6,500	$2.67	$17.4K	898,275	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-06-08	2022-06-09	12,000	$2.67	$32.0K	903,775	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-06-08	2022-06-09	12,000	$44.09	$529.1K	891,775	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-04-29	2022-05-02	4,000	—	$0	364,999	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-04-29	2022-05-02	4,000	$2.67	$10.7K	895,775	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-04-29	2022-05-02	4,000	$44.43	$177.7K	891,775	SEC↗
APLS Apellis Pharmaceuticals, I	J Other deriv	2022-04-21	2022-05-02	11,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2022-04-21	2022-05-02	1,875	—	$0	891,775	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-02-10	2022-02-14	1,057	$47.12	$49.8K	893,650	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-01-28	2022-02-01	931	$38.59	$35.9K	894,707	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-21	2022-01-25	36,951	—	$0	36,951	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-21	2022-01-25	26,051	—	$0	895,638	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-06-24	2021-06-25	6,250	—	$0	368,999	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-06-24	2021-06-25	6,250	$2.67	$16.7K	875,837	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-06-24	2021-06-25	6,250	$65.61	$410.1K	869,587	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-05-24	2021-05-25	6,250	—	$0	375,249	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-05-24	2021-05-25	6,250	$2.67	$16.7K	875,837	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-05-24	2021-05-25	6,250	$47.40	$296.3K	869,587	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-04-28	2021-04-29	4,500	—	$0	381,499	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-04-28	2021-04-29	4,500	$2.67	$12.0K	869,587	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-04-23	2021-04-26	6,250	—	$0	385,999	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-04-23	2021-04-26	6,250	$2.67	$16.7K	871,337	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-04-23	2021-04-26	6,250	$46.13	$288.3K	865,087	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-03-10	2021-03-11	6,250	—	$0	392,249	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-03-10	2021-03-11	6,250	$50.74	$317.1K	865,087	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-03-10	2021-03-11	6,250	$2.67	$16.7K	871,337	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2021-02-10	2021-02-11	688	$47.72	$32.8K	865,087	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	11,250	—	$0	11,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	45,000	—	$0	45,000	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	1,875	—	$0	865,775	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	7,500	—	$0	863,900	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2020-03-10	2020-03-12	161,656	—	$0	847,025	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-13	2020-02-14	117,205	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-13	2020-02-14	55,398	$40.98	$2.27M	1,008,681	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-13	2020-02-14	117,205	$2.14	$250.8K	1,064,079	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-12	2020-02-14	117,206	—	$0	117,205	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-12	2020-02-14	117,206	$2.14	$250.8K	998,949	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-12	2020-02-14	52,075	$42.80	$2.23M	946,874	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2020-02-10	2020-02-12	56,250	—	$0	56,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2020-02-10	2020-02-12	9,375	—	$0	891,118	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-25	2019-09-26	1,010	$25.64	$25.9K	881,743	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-25	2019-09-26	20,531	$25.24	$518.2K	882,753	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-24	2019-09-25	20,307	$24.56	$498.7K	904,579	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-24	2019-09-25	1,295	$24.96	$32.3K	903,284	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-23	2019-09-25	100	$25.53	$2.6K	924,886	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-23	2019-09-25	20,758	$25.07	$520.4K	924,986	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2019-02-08	2019-02-12	95,000	—	$0	95,000	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2018-05-07	2018-05-09	384,292	—	$0	945,744	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2018-02-16	2018-02-21	110,000	—	$0	110,000	SEC↗